Related by context. All words. (Click for frequent words.) 71 transgenic mouse models 71 bronchial epithelial cells 71 tumorigenicity 71 murine model 70 gastrointestinal stromal tumors GISTs 70 antiangiogenic therapy 69 peptide antigens 69 GPx 69 ERK signaling 69 humoral responses 69 antiproliferative effects 69 lymphoid cells 69 mutated K ras 69 NOD mice 69 Estrogen Receptor 68 ABL1 68 beta1 integrin 68 transgene expression 68 aT cell 68 thymidine kinase 68 Clusterin 68 transgenic rats 68 cisplatin resistant 68 NOD mouse 68 HbF 68 Prognostic factors 68 S. maltophilia 68 busulfan 68 diagnostic biomarker 68 Nedd4 68 chemosensitivity 68 protein tyrosine phosphatase 68 missense mutations 68 airway hyperresponsiveness 68 flavopiridol 67 antiangiogenic agent 67 Lymphoid 67 Leydig cell 67 developmental neurotoxicity 67 microsatellite instability 67 PARP inhibition 67 induced sputum 67 pharmacodynamic PD 67 imatinib resistance 67 kallikrein 67 SSc 67 bleomycin 67 androgen receptor AR 67 biomarker assay 67 extramedullary 67 FDG PET imaging 67 Th2 cytokines 67 differential gene expression 67 HepG2 cells 67 anti CD3 67 aminotransferase 67 metastatic neuroendocrine tumors 67 interleukin IL -# 67 gastric adenocarcinoma 67 molecular abnormalities 67 potent cytotoxic 67 abacavir Ziagen 67 isotype 67 miRNA expression 67 NSCLC tumors 67 immunopathology 67 immunoregulatory 67 immune modulating 67 endothelial activation 66 thalidomide Thalomid 66 innate immune responses 66 hepatoma 66 receptor inhibitor 66 annexin 66 IgM antibody 66 neuroregenerative 66 immunotoxin 66 prostate cancer PCa 66 HuR 66 squamous cell lung cancer 66 virulence genes 66 etiologic 66 effector function 66 tryptase 66 serum antibodies 66 liposome formulation 66 #β estradiol 66 antisense inhibitor 66 uricase 66 nanocarrier 66 azacytidine 66 HLA DRB1 * 66 chlamydial 66 pDCs 66 CD# CD# 66 transgenic mouse model 66 gefitinib Iressa 66 RRM1 66 assay detects 66 HCV replicon 66 receptor subtypes 66 antitumour activity 66 serologic tests 66 histone deacetylase inhibitor 66 epithelial tumors 66 mGluR2 NAM 66 hepatocellular carcinomas 66 chromosomal aberrations 66 antiapoptotic 66 immunohistochemical analysis 66 bortezomib Velcade 66 ERalpha 66 FLT3 66 glycosylated 66 intracellular bacteria 66 potent inducer 66 oxysterols 66 cytostatic 66 urothelial cancer 66 transcranial Doppler ultrasound 66 tissue transglutaminase 66 Gleevec resistant 66 radioimmunotherapy RIT 66 Lymph node 66 hypoxic tumors 66 CCR2 66 Beta Amyloid 66 molecular determinants 66 osteoblastic 65 thrombin receptor 65 unconjugated 65 Mutation Analysis 65 Tarvacin 65 cytotoxicity assays 65 C#BL 6 mice 65 antisense inhibitors 65 neuro endocrine 65 thyrotropin 65 fluconazole resistant 65 MDR1 65 recombinant erythropoietin 65 Onconase 65 replicon 65 Immunohistochemical analysis 65 rhITF 65 vimentin 65 HLA B# 65 Temsirolimus 65 immunological responses 65 demyelinating 65 etiologic agent 65 Akt activation 65 PC# cells 65 monocytic 65 K ras mutations 65 preclinical efficacy 65 IL2 65 gene polymorphisms 65 selective inhibition 65 antiangiogenesis 65 metaplasia 65 antimitotic 65 haematologic 65 MGd 65 preclinically 65 alveolar epithelial cells 65 antiangiogenic agents 65 NKX#.# 65 Cardiotoxicity 65 HepDirect prodrug 65 replicase 65 demonstrated antitumor activity 65 myeloproliferative diseases 65 kDa protein 65 vitro assay 65 stably transfected 65 NOD SCID mice 65 tumoral 65 IL 1ß 65 selective modulator 65 radiolabeled 65 Genotypes 65 LHRH receptor positive 65 LPS induced 65 florbetaben 65 humanized monoclonal 65 AChE inhibitors 65 kinase inhibition 65 E#F# 65 epithelial barrier 65 ENMD # 65 putative biomarkers 65 isoenzymes 65 tumor specific antigen 65 RAV# 65 humoral immune response 65 monocytes macrophages 65 antitumor efficacy 65 gene rearrangements 65 pleiotropic 65 Alequel 65 Monoclonal 65 K ras gene 65 potent inhibition 65 antisense inhibition 65 neurotrophic 65 intratumoral injection 65 erythropoietic 65 Cytochrome P# 65 luciferase reporter 65 outer membrane proteins 65 ductal adenocarcinoma 65 Epstein Barr virus EBV 65 splice variants 65 MMP9 65 HER2 expression 65 alpha fetoprotein AFP 65 5alpha reductase 65 BRAF V#E mutation 65 PTPN# 65 anti androgens 65 T#I [002] 65 metastatic malignant 65 histological subtype 65 TLR9 agonists 65 mitochondrial toxicity 65 Pim kinases 65 PCA3 gene 65 prostate carcinoma 65 ABCB1 65 humanized monoclonal antibodies 65 redox active 65 interferon γ 65 Upregulation 65 endogenous ligands 65 distinct subtypes 65 mediated inhibition 65 enterococcal 65 immunoreactivity 65 clonal expansion 64 HLA DR4 64 induced cytotoxicity 64 plasma pharmacokinetics 64 non nucleoside 64 colorectal tumor 64 trans retinoic acid 64 EGFR inhibition 64 EGFR HER2 64 mouse xenograft models 64 MT1 MMP 64 molecular biomarkers 64 haematopoietic 64 refractory prostate cancer 64 CD# expression [001] 64 membranous nephropathy 64 neuroblastoma tumors 64 TPMT 64 activin 64 COL#A# 64 Fibroblast 64 PPARγ 64 neovascular 64 DNA intercalator 64 antitumour 64 immunohistochemical staining 64 MVA MUC1 IL2 64 malignant phenotype 64 gene amplification 64 prognostic biomarker 64 potent antiproliferative 64 mTOR inhibition 64 mononuclear 64 C1q 64 HER2/neu 64 alpha#beta# 64 arterial calcification 64 metabolomic profiles 64 TEL AML1 64 P selectin 64 HER2 overexpression 64 Antigen Specific 64 clinicopathological 64 Vidaza azacitidine 64 biochemical abnormalities 64 Bleomycin 64 hESC derived cardiomyocytes 64 lactate dehydrogenase LDH 64 Trp p8 64 p# MAPK 64 therapeutically relevant 64 clade B 64 NKG2D 64 hematopoietic cancers 64 NF kB pathway 64 TNFalpha 64 CYP #D# 64 syngeneic 64 small molecule activators 64 BRAF V#E 64 glycopeptides 64 genetic polymorphisms 64 peroxidation 64 FGFR4 64 bone marrow stromal cells 64 GRNCM1 64 beta1 64 xenograft model 64 prognostic significance 64 PDGF receptor 64 N glycan 64 N Myc 64 cardiac troponin 64 monoclonal antibody mAb 64 IgG1 antibody 64 demethylating agent 64 mTOR inhibitors 64 synthetic analogues 64 tumor subtypes 64 intestinal permeability 64 p# biomarker 64 HER2 receptor 64 serous ovarian cancer 64 colon carcinoma 64 synovial cells 64 Squalamine 64 Fc gamma receptor 64 erythropoiesis 64 depsipeptide 64 MYCN amplification 64 chemoresistant 64 microsomal 64 Sipuleucel T 64 JAK2 inhibitors 64 induced anemia 64 LRP5 64 trophoblast cells 64 sarcomatoid 64 synthases 64 p#NTR 64 bispecific 64 mtDNA mutations 64 folate receptor 64 leukocyte recruitment 64 TOP2A 64 immunohistochemical 64 p# antigen 64 thyroglobulin 64 vitro experiments 64 monoclonal anti 64 pharmacodynamic markers 64 Immunohistochemical 64 prognostic marker 64 inosine 64 ADAMTS# 64 gene polymorphism 64 immunostaining 64 myeloproliferative 64 Immunohistochemical staining 64 Lipoic acid 64 siRNA knockdown 64 metastatic lymph nodes 64 osteosarcomas 64 parthenolide 64 Cyclin E 64 p# Shc 64 immunoblot 64 monogenic 64 MDCK 64 mineralocorticoid 64 chemo immunotherapy 64 ALK inhibitors 64 anthracycline chemotherapy 64 Interferon beta 64 Alkaline Phosphatase 64 immunofluorescence microscopy 64 susceptibility loci 64 cytidine 64 TLR9 agonist 64 anti CD3 antibody 64 HIF 1a 64 Squamous 64 riociguat 64 thymidylate synthase TS 64 radionuclide therapy 64 Genetic variants 64 neuropilin 64 degranulation 64 B7 H3 64 tyrosine phosphorylation 64 bronchoalveolar 64 inhibits VEGF 64 lupus anticoagulant 64 ERBB2 64 ligand induced 64 BRAF inhibitors 64 neutralizing antibody responses 64 Elevated serum 64 YONDELIS R 64 ovarian carcinoma 64 herpesviruses 64 HLA DQ2 64 PON1 gene 64 polycythemia vera PV 63 radiosensitivity 63 CDK4 63 serum biomarkers 63 PGC 1α 63 E. faecalis 63 carcinoembryonic antigen 63 chimeric monoclonal antibody 63 HuLuc# 63 fibrosarcoma 63 constitutively expressed 63 Aplidin 63 somatostatin receptors 63 plasminogen activator 63 Fas ligand 63 renoprotective 63 humanised monoclonal antibody 63 Th2 immune 63 CLL cells 63 SNP rs# [001] 63 irreversible inhibitor 63 A3 adenosine receptor 63 KRAS oncogene 63 mutational analysis 63 erlotinib Tarceva 63 amyloidogenic 63 IGFBP2 63 histologic subtype 63 kinase gene 63 multigenic 63 adeno associated viruses 63 FUS1 63 OMP #M# 63 trastuzumab Herceptin ® 63 Cytotoxic 63 proteomic analysis 63 anti tumoral 63 CD4 + T lymphocytes 63 pertussis toxin 63 breast cancer metastasis 63 apoptosis inducing 63 #ß 63 beta lactam antibiotic 63 cardioprotective effects 63 nucleotide analog 63 pegylated liposomal doxorubicin 63 annexin V 63 adipogenic 63 genomic alterations 63 NS#/#A protease 63 basophils 63 TRAIL induced apoptosis 63 uPAR 63 histopathological 63 quasispecies 63 Decitabine 63 Interferon Beta 63 Genetic variation 63 Anticalins ® 63 etanercept Enbrel 63 β1 63 adrenoceptor 63 perilipin 63 MCF7 63 thyroid carcinoma 63 motexafin gadolinium 63 hypermethylated 63 HMGCR 63 mitogen activated protein kinases 63 recombinants 63 selective agonists 63 ApoA l 63 somatostatin analogs 63 radiolabeled TM# 63 miRview ™ squamous 63 mGlu2 3 63 IL #R 63 KRAS status 63 PPARgamma 63 pain palliation 63 proliferative disorders 63 Oncogenic 63 Apatone 63 MTT assay 63 Polymerase 63 TGF beta1 63 Degarelix 63 lesional 63 ultrastructural 63 transfected cells 63 neuroactive 63 lysyl oxidase 63 ALB # 63 compound AEZS 63 MAGE A3 ASCI 63 prostate cancer CaP 63 JAK2 inhibitor 63 humanised antibody 63 circadian genes 63 promoter hypermethylation 63 pDC 63 phenotyping 63 vitro cytotoxicity 63 histologic diagnosis 63 KRAS mutation 63 somatic mutations 63 multiplex assay 63 Epstein Barr Virus EBV 63 MAP kinase 63 eIF 4E 63 unmutated 63 pancreatic ductal 63 estrogen estradiol 63 phospholipase 63 neuronal dysfunction 63 galectin 63 telomere dysfunction 63 Hp2 2 63 phosphorylated tau 63 pediatric acute lymphoblastic 63 receptor blocker 63 capsular polysaccharide 63 mGluR5 antagonist 63 cardiogenic 63 hapten 63 effector protein 63 targeting CD# 63 transfection efficiency 63 Transcription Factor 63 immune modulatory 63 Human Leukocyte Antigen 63 cytotoxic T lymphocyte 63 tumor xenograft models 63 isoenzyme 63 p# activation 63 nonhuman primate model 63 BCL#A 63 immunofluorescence staining 63 NPM1 63 HOXB# 63 Fc receptor 63 neoplastic 63 TNF α 63 gemcitabine Gemzar 63 circulating endothelial 63 gastric carcinoma 63 Lpathomab 63 CDK inhibitor 63 Fenretinide 63 coexpression 63 genes differentially expressed 63 Superoxide 63 OvaRex MAb 63 lymphocyte counts 63 HDACi 63 neuropathologic 63 papillary renal cell carcinoma 63 radiolabeled monoclonal antibody 63 Aromatase 63 microarray gene expression 63 mediated apoptosis 63 anti angiogenic agents 63 pathogenic mechanisms 63 DNA methylation patterns 63 HER2 neu 63 antitumoral 63 Histone 63 antibody mediated 63 germline mutations 63 nodal metastasis 63 phenotypic expression 63 experimentally induced 63 antitumor effect 63 inflammatory cytokine 63 NMDA antagonists 63 cynomolgus monkeys 63 amyloid imaging 63 DNA demethylation 63 act synergistically 63 Inactivation 63 Akt inhibitor 63 rifamycins 63 miR #a [002] 63 constipation predominant IBS 63 Assay Kits 63 ANCA associated 63 CCR1 63 rBChE 63 Cytotoxic T 63 pyridostigmine 63 bacterial virulence 63 Safinamide 63 atherothrombotic 63 subcellular localization 63 IntroductionThe 63 dasatinib Sprycel 63 NQO1 63 microglial activation 63 endocrine therapies 63 Cyclosporin 63 CD# expression [002] 63 sphingolipid 63 protease activated 63 Aviptadil 63 Tumor Necrosis Factor 63 TNFa 63 adrenocortical 63 systemic amyloidosis 63 beta subunit 63 DNA methyltransferases 63 sCD# 63 cystatin 63 pentamidine 63 cellular immunotherapy 63 pegylated recombinant 63 endothelin receptor 63 Leukemias 63 IGF1R 63 interferon IFN 63 oncoproteins 63 GLP 1R 63 experimental autoimmune encephalomyelitis 63 BALB c mice 63 pancreatic ductal adenocarcinoma 63 molecular diagnostic assay 63 Chemokine Receptor 63 Cdc7 63 prostate carcinomas 63 xenograft models 63 HIF 1α 63 baseline LDH 63 muscarinic 63 CRF antagonists 63 urothelial carcinoma 63 Protelos R 63 bone scintigraphy 63 denileukin diftitox 63 mutated p# 63 IgA deficiency 63 infected macrophages 63 Phenotypic 63 receptor blockers 63 PEGylated interferon 63 c KIT 63 galiximab 63 N. gonorrhoeae 63 chemokine receptor 63 SGLT2 inhibitors 63 mda 7 63 lung epithelial cells 63 GSK3B 63 cytotoxic therapies 63 PI3K/mTOR 63 Prostaglandins 63 GBA mutations 63 Enzastaurin 63 DermaVir 62 adenylate cyclase 62 IFN g 62 malignant ascites 62 prognostic indicators 62 PSMA ADC 62 retaspimycin 62 genotypic resistance 62 CBLC# 62 dimeglumine 62 Lp PLA 2 62 enzymatically active 62 cytotoxic effects 62 druggable targets 62 Pharmacokinetics PK 62 invasive ductal 62 thiopurine 62 amyloid formation 62 differentially expressed genes 62 genomic biomarker 62 mycosis fungoides 62 adducts 62 relapsed MM 62 Human cl 62 orally dosed 62 STAT3 signaling 62 FTIs 62 survivin expression 62 potent anti angiogenic 62 proto oncogene 62 M. pneumoniae 62 ELISPOT assay 62 cathepsin B 62 Leukotriene 62 FGFs 62 liposomal doxorubicin 62 TLR3 62 isotypes 62 Francisella 62 Dacogen decitabine 62 Pegylated 62 FGFR1 62 AT1R 62 TSLP 62 imatinib Gleevec 62 posttranslational modification 62 lenalidomide dexamethasone 62 liposomal amphotericin B 62 GRP# 62 secretory pathway 62 Pemetrexed 62 p# mitogen activated 62 Azedra 62 c fos 62 paricalcitol 62 selective adenosine 62 antitumor 62 gemcitabine Gemzar ® 62 DGAT1 62 Janus kinase 62 embryonal carcinoma 62 covalently bound 62 kidney urologic 62 neutralizing antibody 62 inflammatory biomarkers 62 highly immunogenic 62 Troponin T 62 mesangial 62 cyclin E 62 chromosomal rearrangement 62 biomolecular interactions 62 immunotoxins 62 Ferritin 62 complement inhibitor eculizumab 62 PB1 F2 62 recurrent glioblastoma multiforme GBM 62 trabectedin 62 oligomerization 62 cytotoxin 62 chemopreventive agents 62 thermosensitive 62 NB S# strontium malonate 62 AST ALT 62 Glucocorticoids 62 bullous 62 immunocompetent 62 Neuropeptide Y 62 autoimmune pancreatitis 62 proapoptotic 62 IRDye 62 PET tracer 62 pharmacodynamic effects 62 induced phosphorylation 62 antigenic epitopes 62 Lewy bodies DLB 62 antitrypsin 62 PKCi 62 TMPRSS2 ERG 62 colorectal adenocarcinoma 62 glomerular 62 TIMP 1 62 apoptotic pathway 62 angiographically 62 polyclonal 62 peptidic 62 cells overexpressing 62 ESR1 62 cyclophilin D 62 serum TSH 62 hemoglobins 62 KRAS mutations 62 tumor histology 62 enkephalin 62 TGF ß 62 carcinoids 62 Secretase 62 parasitemia 62 EGF receptors 62 pathogenetic 62 IFN α 62 immunoregulation 62 HER2 amplification 62 substrate specificity 62 pan HDAC inhibitor 62 Endotoxin 62 ER alpha 62 HER2 HER3 62 BRCA deficient 62 Pgp 62 cardiolipin 62 IGF IR 62 humanized antibody 62 vasoactive 62 beta interferons 62 ^ sup #m 62 intracellular accumulation 62 MTHFR gene 62 ELISPOT 62 Fibroblast Growth Factor Receptor 62 KLF4 62 corticosteroid dexamethasone 62 transcriptomic 62 allergic airway inflammation 62 Activating mutations 62 hPTH #-# 62 DFMO 62 alkaline phosphatase ALP 62 Mutational 62 SMAD4 62 aggregated Abeta 62 immunoblotting 62 Treg cell 62 SMN1 62 TLR antagonist 62 colocalization 62 gastric carcinomas 62 NFkB 62 melatonin receptor 62 HERmark assay 62 5 HT4 receptor 62 S/GSK# 62 hematological parameters 62 APOE genotype 62 fosbretabulin 62 mimetic compounds 62 oncogenic transformation 62 pharmacologic intervention 62 GSTP1 62 anti angiogenic drugs 62 monomeric 62 cytoprotective 62 FDG PET scans 62 pleiotropic effects 62 autoreactive 62 selective agonist 62 oral prodrug 62 potently inhibited 62 Plasmid DNA 62 Marqibo TM 62 mineralocorticoid receptor 62 pretreatment serum 62 chronic inflammations 62 irinotecan oxaliplatin 62 ON #.Na 62 pharmacokinetic interactions 62 hypomethylating agent 62 vascular disrupting agents 62 OHR/AVR# 62 methylation markers 62 liposomal formulation 62 MAPK pathway 62 elastase 62 COX2 62 PON1 62 prostaglandin E 62 cDNA microarray 62 MiCK assay 62 bovine thrombin 62 PAR1 62 glutamate signaling 62 allelic variants 62 potent stimulator 62 immunoreactive 62 Legg Calvé Perthes disease 62 targeted antifolate 62 Thiovir 62 Alpha lipoic acid 62 mesothelin 62 antiandrogens 62 teratogens 62 proteasome inhibitors 62 cAMP signaling 62 VEGF inhibitors 62 ploidy 62 acadesine 62 ependymomas 62 C. pneumoniae 62 Lodamin 62 Haptoglobin 62 immunofluorescent 62 CYT# potent vascular disrupting 62 cranial irradiation 62 proteinase 62 FDG-PET/CT 62 physiologic mechanisms 62 Allogeneic 62 ultrastructure 62 steroidogenic 62 hydroxylase 62 cyto 62 anti CD# antibodies 62 Oncotype 62 deacetylation 62 PI3K Akt 62 Flt3 62 RAS blockers 62 ergot alkaloids 62 motor neuron degeneration 62 myocardial infarct size 62 plasmacytoid dendritic cells 62 potent inhibitors 62 microRNA expression 62 CIN2 + 62 Modrenal 62 TIMP 62 cytologic 62 selectively inhibited 62 amine oxidase 62 Xelox 62 heparanase 62 mecamylamine 62 enzyme inhibitor 62 drug metabolizing enzymes 62 calcitonin gene related 62 clusterin 62 mertansine 62 soluble CD# 62 pulmonary metastases 62 GCase 62 prostate epithelial cells 62 G#DT 62 IFN γ 62 liposomes containing 62 EGFR TKIs 62 spontaneous regression 62 coactivators 62 NRTI resistance 62 γδ T cells 62 labetuzumab 62 cytokine signaling 62 PLA2 62 triiodothyronine 62 miRs 62 telomerase inhibitor 62 Factor VIIa 62 cytolytic activity 62 murine antibodies 62 Darinaparsin 62 renal fibrosis 62 dexrazoxane 62 Camptothecin 62 MMP# 62 CDX2 62 FGFR3 62 microRNA profiling 62 WT1 62 upregulates 62 Dendritic cell 62 IFNg 62 enteroviral infection 62 Protein Kinase C 62 peptide inhibitors 62 antimicrobial peptide 62 hormone receptor status 62 demyelinating diseases 62 therapeutically useful 62 M1 muscarinic 62 BRCA1 BRCA2 62 neovascularisation 62 PIK3CA 62 antisera 62 MEK ERK 62 N acetyl 62 gene inactivation 62 Medullary thyroid cancer 62 seminomas 62 protein isoforms 62 EGFR receptor 62 inhibitor RG# 62 tumor subtype 62 humanized mouse 62 mRNA transcripts 62 HLA DR 62 intratumoral 62 recombinant antibodies 62 novel immunotherapeutic 62 skeletal metastases 62 eotaxin 62 nucleolar 62 histone acetylation 62 breast carcinoma 62 SCD1 62 clinicopathologic 62 hypericin 62 glioblastoma tumors 62 CD#c 62 ZACTIMA 62 hypothalamic pituitary 62 tumor necrosis 62 hypomethylation 62 mimetics 62 cardiac troponin T 62 HuMax 62 β amyloid 62 immunoglobulin Ig 62 endostatin 62 enzyme inhibitors 62 molecular mimicry 62 pathophysiologic mechanism 62 CEACAM1 62 lenalidomide Revlimid